ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
40,003.59
0.34%
Gold vs US Dollar
2,413.935
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,919.49
-0.24%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Ampio Pharmaceuticals Inc (AMPE)

  7. Ampio Pharmaceuticals Inc (AMPE) News

Ampio Pharmaceuticals (AMPE)

Ampio Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:AMPE
DateTimeSourceHeadlineSymbolCompany
03/04/202419:33PR Newswire (US)Ampio Pharmaceuticals Received Audit Opinion with Going Concern ExplanationAMEX:AMPEAmpio Pharmaceuticals Inc
25/03/202421:00PR Newswire (US)Ampio Announces Voluntary Delisting and SEC DeregistrationAMEX:AMPEAmpio Pharmaceuticals Inc
05/03/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AMPEAmpio Pharmaceuticals Inc
28/02/202420:49Edgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
28/02/202420:48Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsAMEX:AMPEAmpio Pharmaceuticals Inc
28/02/202420:47Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsAMEX:AMPEAmpio Pharmaceuticals Inc
28/02/202420:46Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementAMEX:AMPEAmpio Pharmaceuticals Inc
28/02/202420:45Edgar (US Regulatory)Form RW - Registration Withdrawal RequestAMEX:AMPEAmpio Pharmaceuticals Inc
15/02/202414:31Edgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
14/02/202422:45PR Newswire (US)Ampio Provides Update on Results from Pre-IND Enabling StudiesAMEX:AMPEAmpio Pharmaceuticals Inc
25/01/202421:31Edgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
25/01/202421:18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AMPEAmpio Pharmaceuticals Inc
24/01/202422:16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AMPEAmpio Pharmaceuticals Inc
11/01/202421:20Edgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
11/01/202421:15PR Newswire (US)Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal ActionsAMEX:AMPEAmpio Pharmaceuticals Inc
21/12/202321:25Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:AMPEAmpio Pharmaceuticals Inc
14/11/202321:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AMPEAmpio Pharmaceuticals Inc
02/11/202313:30Edgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
31/10/202313:00PR Newswire (US)Ampio Pharmaceuticals to Present at the Emerging Growth ConferenceAMEX:AMPEAmpio Pharmaceuticals Inc
27/10/202319:10Edgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
06/10/202319:56Edgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
05/10/202321:30PR Newswire (US)Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201AMEX:AMPEAmpio Pharmaceuticals Inc
04/10/202321:15Edgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
02/10/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AMPEAmpio Pharmaceuticals Inc
26/09/202314:15PR Newswire (US)Ampio Pharmaceuticals to Present at the Emerging Growth ConferenceAMEX:AMPEAmpio Pharmaceuticals Inc
22/09/202321:30Edgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
18/09/202321:30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:AMPEAmpio Pharmaceuticals Inc
31/08/202321:19Edgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
31/08/202311:30PR Newswire (US)Ampio Pharmaceuticals Announces Reverse Stock SplitAMEX:AMPEAmpio Pharmaceuticals Inc
15/08/202321:56Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:AMPEAmpio Pharmaceuticals Inc
 Showing the most relevant articles for your search:AMEX:AMPE

Your Recent History

LSE
BGEO
Bank Of Georgia
LSE
TPL
Tethys
LSE
GKP
Gulf Keystone Petroleum
LSE
ENET
Ethernity Networks
LSE
EDEN
Eden Research
LSE
XLM
Xlmedia
LSE
NEXN
Nexxen
LSE
TBCG
Tbc Bank
LSE
CGEO
Georgia Capital
NYSE
STNG
Scorpio Tankers
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved